Thus, this systematic review aimed to elucidate the potential role of circulating levels of Nrg4 as a biomarker for the severity of obesity, GDM, T2DM, NAFLD, and CVD. Here, NRG4 is linked to metabolic dysfunction-associated steatotic liver disease.